TAM receptors in apoptotic cell clearance, autoimmunity, and cancer

Autoimmunity

Volumn 46, Issue 5, 2013, Pages 294-297

  Nguyen, Khanh Quynh ^a   Tsou, Wen I ^a   Kotenko, Sergei ^a   Birge, Raymond B ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Efferocytosis; Gas6; Immune tolerance; Phosphatidylserine; TAM receptors

Indexed keywords

ANTINEOPLASTIC AGENT; AXL PROTEIN; BAVITUXIMAB; CISPLATIN; MER PROTEIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; R 428; STAT1 PROTEIN; TYRO 3 PROTEIN; UNCLASSIFIED DRUG;

APOPTOSIS; AUTOIMMUNITY; DRUG POTENTIATION; DRUG TARGETING; HUMAN; IMMUNOLOGICAL TOLERANCE; MACROPHAGE; NEOPLASM; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REVIEW; TRANSCRIPTION REGULATION; TUMOR CELL; TUMOR IMMUNITY;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; CELL DEATH; CELL SURVIVAL; HUMANS; NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES;

EID: 84880354695     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.3109/08916934.2013.794515     Document Type: Review

References (42)

1. Savill, J., and V. Fadok. 2000. Corpse clearance defines the meaning of cell death. Nature 407: 784
2. Fadok, V. A., D. L. Bratton, A. Konowal, et al. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/ paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest 101: 890
3. Thorp, E.,D. Cui,D. M. Schrijvers,G.Kuriakos, and I. Tabas. 2008. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Arterioscler. Thromb. Vasc. Biol 28: 1421
4. Wallet, M. A., P. Sen, R. R. Flores, et al. 2008. MerTK is required for apoptotic cell-induced T cell tolerance. J. Exp. Med 205: 219
5. Scott, R. S., E. J. McMahon, S. M. Pop, et al. 2001. Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature 411: 207
6. Botto, M., C. Dell'Agnola, A. E. Bygrave, et al. 1998. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet 19: 56
7. Gaipl, U. S., A. Kuhn, A. Sheriff, et al. 2006. Clearance of apoptotic cells in human SLE. Curr. Dir. Autoimmun 9: 173
8. Elliott, M. R., and K. S. Ravichandran. 2010. Clearance of apoptotic cells: Implications in health and disease. J. Cell. Biol 189: 1059
9. Linger, R. M., A. K. Keating, H. S. Earp, and D. K. Graham. 2008. TAM receptor tyrosine kinases: Biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv. Cancer Res 100: 35
10. Cohen, P. L., R. Caricchio, V. Abraham, et al. 2002. Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mermembrane tyrosine kinase. J. Exp.Med 196: 135
11. Lu, Q., and G. Lemke. 2001. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science 293: 306
12. Camenisch, T. D., B. H. Koller, H. S. Earp, and G. K. Matsushima. 1999. A novel receptor tyrosine kinase, Mer, inhibits TNF-Alpha production and lipopolysaccharideinduced endotoxic shock. J. Immunol 162: 3498
13. Sen, P.,M. A.Wallet, Z. Yi, et al. 2007. Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood 109: 653
14. Gohlke, P. R., J. C. Williams, and B. J. Vilen. 2009. The receptor tyrosine kinase MerTK regulates dendritic cell production of BAFF. Autoimmunity 42: 183
15. Baumann, I., W. Kolowos, R. E. Voll, et al. 2002. Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum 46: 191
16. Shao,W. H., Y. Zhen, R. A. Eisenberg, and P. L. Cohen. 2009. The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells. Clin. Immunol 133: 138
17. Shao,W. H., A. P. Kuan, C.Wang, et al. 2010. Disrupted Mer receptor tyrosine kinase expression leads to enhanced MZ B-cell responses. J. Autoimmun 35: 368
18. Rahman, Z. S., W. H. Shao, T. N. Khan, Y. Zhen, and P. L. Cohen. 2010. Impaired apoptotic cell clearance in the germinal center by Mer-deficient tingible body macrophages leads to enhanced antibody-forming cell and germinal center responses. J. Immunol 185: 5859
19. Cheong, H. S., S. O. Lee, and C. B. Choi. 2007. MERTK polymorphisms associated with risk of haematological disorders among Korean SLE patients. Rheumatology (Oxford) 46: 209
20. Wu, J., C. Ekman, A. Jonsen, et al. 2011. Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis. Arthritis Res. Ther 13: R62
21. Suh, C. H., B. Hilliard, S. Li, J. T. Merrill, and P. L. Cohen. 2010. TAM receptor ligands in lupus: Protein S but not Gas6levels reflect disease activity in systemic lupus erythematosus. Arthritis Res. Ther 12: R146
22. Caberoy, N. B., Y. Zhou, and W. Li. 2010. Tubby and tubbylike protein 1 are new MerTK ligands for phagocytosis. EMBO J 29: 3898
23. Caberoy, N. B., G. Alvarado, J. L. Bigcas, and W. Li. 2012. Galectin-3 is a new MerTK-specific eat-me signal. J. Cell. Physiol 227: 401
24. Wong, C. C., and W. M. Lee. 2002. The proximal cis-Acting elements Sp1, Sp3 and E2F regulate mouse mer gene transcription in Sertoli cells. Eur. J. Biochem 269: 3789
25. Mudduluru, G., J. H. Leupold, P. Stroebel, and H. Allgayer. 2010. PMA up-regulates the transcription of Axl by AP-1 transcription factor binding to TRE sequences via the MAPK cascade in leukaemia cells. Biol. Cell 103: 21
26. McColl, A., S. Bournazos, S. Franz, et al. 2009. Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J. Immunol 183: 2167
27. Zahuczky, G., E. Kristof, G. Majai, and L. Fesus. 2011. Differentiation and glucocorticoid regulated apopto-phagocytic gene expression patterns in human macrophages. Role of Mertk in enhanced phagocytosis. PLoS One 6: E21349
28. Galvan, M. D., D. B. Foreman, E. Zeng, J. C. Tan, and S. S. Bohlson. 2012. Complement component C1q regulates macrophage expression of Mer tyrosine kinase to promote clearance of apoptotic cells. J. Immunol 188: 3716
29. Budagian, V., E. Bulanova, Z. Orinska, et al. 2005. Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum. Mol. Cell Biol 25: 9324
30. Seitz, H. M., T. D. Camenisch, G. Lemke, H. S. Earp, and G. K. Matsushima. 2007. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. J. Immunol 178: 5635
31. Nandrot, E. F., K. E. Silva, C. Scelfo, and S. C. Finnemann. 2012. Retinal pigment epithelial cells use a MerTK-dependent mechanism to limit the phagocytic particle binding activity of alphavbeta5 integrin. Biol. Cell 104: 326
32. Sandahl, M., D. M. Hunter, K. E. Strunk, H. S. Earp, and R. S. Cook. 2010. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. BMC Dev. Biol 10: 122
33. Rothlin, C. V., S. Ghosh, E. I. Zuniga, M. B. Oldstone, and G. Lemke. 2007. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell 131: 1124
34. Sharif, M. N., D. Sosic, C. V. Rothlin, et al. 2006. Twist mediates suppression of inflammation by type I IFNs and Axl. J. Exp. Med 203: 1891
35. Rothlin, C. V., and G. Lemke. 2010. TAM receptor signaling and autoimmune disease. Curr. Opin. Immunol 22: 740
36. Png, K. J., N. Halber, M. Yoshida, and S. F. Tavazoie. 2011. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature 481: 190
37. Mudduluru, G., P. Ceppi, and R. Kumarswamy. 2011.Regulation of Axl receptor tyrosine kinase expression by miR- 34a and miR-199a/b in solid cancer. Oncogene 30: 2888
38. Apetoh, L., F. Ghiringhelli, A. Tesniere, et al. 2007. Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat.Med 13: 1050
39. Holland, S. J., A. Pan, C. Franci, et al. 2010. R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer.Cancer Res 70: 1544
40. Bondanza, A., V. S. Zimmermann, P. Rovere-Querini, et al. 2004. Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J. Exp. Med 200: 1157
41. He, J.,Y. Yin,T. A. Luster, L.Watkins, and P. E. Thorpe. 2009. Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma. Clin. Cancer Res 15: 6871
42. Marconescu, A., and P. E. Thorpe. 2008. Coincident exposure of phosphatidylethanolamine and anionic phospholipids on the surface of irradiated cells. Biochim. Biophys. Acta 1778: 2217